Why it matters
The finding makes billing ascertainment, documented component delivery, and oversight important while not establishing a current utilization rate, inappropriate care, or ineffectiveness.
Decision implication
Track documented component delivery and claims/encounter ascertainment separately; do not infer care quality or current prevalence from the 2022 finding alone.
Who or what is affected
- CMS
- OIG
- RPM vendors
- clinicians
- medical practices
- Medicare beneficiaries
Evidence and sources
Decision priority: Watch
Source authority: Primary/authoritative · CMS/OIG official sources
Evidence design: Program record
Applicability: Direct
Confidence for the stated claim: High
Freshness: Current
- https://www.cms.gov/training-education/medicare-learning-network/newsletter/mln-connects-newsletter-may-14-2026
- https://oig.hhs.gov/documents/evaluation/10001/OEI-02-23-00260.pdf
- https://oig.hhs.gov/reports/all/2024/additional-oversight-of-remote-patient-monitoring-in-medicare-is-needed/
P4L distinguishes the sourced record from interpretation. Program inclusion, participation, funding, proposal status, or a public listing does not by itself establish clinical effectiveness, endorsement, coverage, or scaled adoption unless the cited source specifically establishes it.
For this decision
Health-system leaders · Payers/employers · Clinicians · Policymakers · Innovators
What P4L is watching next
- Final CY 2027 rules
- enforcement
- audit patterns
- billing trends
- outcome data.
Related proof records
Record provenance
- Last verified
- 2026-09-03
- Source updated
- 2026-05-14
- Revision state
- Version 1.1 limits the 43% finding to 2022 claims and encounter data, adds the billing-ascertainment boundary and OIG sources, revises the decision implication accordingly, and records the September 3, 2026 re-verification.
- Status
- Current oversight · historical 2022 claims/encounter-data finding
- Freshness
- Current
- Version
- 1.1
- Stable ID
- SIG-2026-025